Publicaciones en las que colabora con MARIA DOLORES CHIARA ROMERO (19)

2019

  1. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

  2. Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations

    The Journal of clinical endocrinology and metabolism, Vol. 104, Núm. 11, pp. 5673-5692

2018

  1. SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 295-305

2017

  1. Control of long-distance cell-to-cell communication and autophagosome transfer in squamous cell carcinoma via tunneling nanotubes

    Oncotarget, Vol. 8, Núm. 13, pp. 20939-20960

  2. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate

    Oncotarget, Vol. 8, Núm. 4, pp. 6700-6717

2015

  1. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

    Oral Diseases, Vol. 21, Núm. 7, pp. 899-904

  2. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy

    Head and Neck, Vol. 37, Núm. 8, pp. 1150-1162

2013

  1. Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

    BMC Cancer, Vol. 13

  2. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1αmiR-210 signaling pathway

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 10

2012

  1. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

    Clinical Cancer Research, Vol. 18, Núm. 10, pp. 2828-2837

2009

  1. Increase in gene dosage is a mechanism of HIF-lα constitutive expression in head and neck squamous cell carcinomas

    Genes Chromosomes and Cancer, Vol. 48, Núm. 5, pp. 441-454

  2. Significado pronóstico de la angiogénesis en los carcinomas epidermoides de laringe supraglótica tratados con cirugía

    Acta Otorrinolaringologica Espanola, Vol. 60, Núm. 4, pp. 272-277

  3. The relation between Hypoxia-Inducible Factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer

    Journal of Surgical Oncology, Vol. 99, Núm. 6, pp. 373-378

2008

  1. Alteraciones moleculares en las metástasis ganglionares y sus tumores primarios en los carcinomas epidermoides de laringe

    Acta Otorrinolaringologica Espanola, Vol. 59, Núm. 3, pp. 114-119

  2. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression

    British Journal of Cancer, Vol. 98, Núm. 7, pp. 1274-1284

2007

  1. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph mode metastases: New results for an old question

    Cancer, Vol. 109, Núm. 9, pp. 1791-1798

  2. Relación entre la expresión de FAK y p53 en los carcinomas epidermoides de laringe

    Acta Otorrinolaringologica Espanola, Vol. 58, Núm. 8, pp. 347-351

2006

  1. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number

    Clinical Cancer Research, Vol. 12, Núm. 11 I, pp. 3272-3279

2005

  1. Modelo murino ortotópico de carcinoma epidermoide de cabeza y cuello

    Acta Otorrinolaringologica Espanola, Vol. 56, Núm. 3, pp. 89-95